CNR Institutional Research Information System

TESTA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.548
NA - Nord America 752
EU - Europa 455
SA - Sud America 279
AF - Africa 25
OC - Oceania 4
Totale 3.063
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 709
SG - Singapore 643
CN - Cina 369
BR - Brasile 224
IT - Italia 178
HK - Hong Kong 160
VN - Vietnam 160
FR - Francia 92
KR - Corea 60
BD - Bangladesh 52
NL - Olanda 34
DE - Germania 27
GB - Regno Unito 25
AR - Argentina 22
IN - India 22
JP - Giappone 22
CA - Canada 20
FI - Finlandia 15
MX - Messico 13
EC - Ecuador 11
ID - Indonesia 11
UA - Ucraina 11
IE - Irlanda 9
PL - Polonia 9
IL - Israele 8
IQ - Iraq 8
RU - Federazione Russa 8
SE - Svezia 8
SA - Arabia Saudita 7
ES - Italia 6
ZA - Sudafrica 6
AT - Austria 5
LT - Lituania 5
TR - Turchia 5
UY - Uruguay 5
AL - Albania 4
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
JO - Giordania 4
VE - Venezuela 4
DZ - Algeria 3
GR - Grecia 3
HR - Croazia 3
OM - Oman 3
PE - Perù 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
JM - Giamaica 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
LB - Libano 1
MR - Mauritania 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.063
Salva come PNG Salva come JPEG
Città #
Singapore 395
Santa Clara 199
Hong Kong 159
Hefei 103
San Jose 87
Beijing 80
Lauterbourg 73
Ashburn 65
Seoul 58
Ho Chi Minh City 57
Los Angeles 53
Hanoi 33
New York 27
São Paulo 22
Dallas 20
Tokyo 11
Frankfurt am Main 10
Helsinki 10
Amsterdam 9
Warsaw 9
Da Nang 8
Dublin 8
Düsseldorf 8
Orem 8
Stockholm 8
Brasília 7
Catania 7
Curitiba 7
Milan 7
Minamishinagawa 7
Naples 7
Belo Horizonte 6
Council Bluffs 6
Denver 6
Biên Hòa 5
Buffalo 5
Ha Long 5
Houston 5
Lappeenranta 5
Phoenix 5
Rio de Janeiro 5
Rome 5
Thái Bình 5
Vienna 5
Amman 4
Catalão 4
Chennai 4
City of London 4
Guayaquil 4
Johannesburg 4
London 4
Manchester 4
Montreal 4
Paternò 4
Quito 4
Riyadh 4
Toronto 4
Atlanta 3
Bari 3
Bengaluru 3
Brooklyn 3
Bắc Giang 3
Bắc Ninh 3
Cairo 3
Can Tho 3
Florianópolis 3
Formosa 3
Guarulhos 3
Hải Dương 3
Marseille 3
Montevideo 3
Mosul 3
Munich 3
Natal 3
Osaka 3
Philadelphia 3
Poplar 3
Portsmouth 3
Quận Một 3
Salvador 3
Seeb 3
The Dalles 3
Zagreb 3
Aci Catena 2
Aracaju 2
Asunción 2
Athens 2
Belo Jardim 2
Blumenau 2
Boardman 2
Calgary 2
Campina Grande 2
Caracas 2
Carapicuíba 2
Dakar 2
Dhaka 2
Dourados 2
Falkenstein 2
Fortaleza 2
Guangzhou 2
Totale 1.794
Salva come PNG Salva come JPEG
Nome #
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 117
Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy 117
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 79
SerGenCovid19 - Relazione analisi requisiti SerGenCovid19 74
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 72
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 70
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 69
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 68
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 68
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies 66
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children 65
Effectiveness of apremilast in real life in patients with psoriasis: A longitudinal study 63
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 62
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 60
Perioperative Marinobufagenin (MBG) Measurement May Improve Acute Kidney Injury Risk Assessment in Patients Undergoing Major Cardiac Surgery: A Proof-of-Concept Study 57
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass 57
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 56
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 55
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 51
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 50
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 48
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 48
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 47
A POLYMORPHISM IN THE SIRT-1 GENE ASSOCIATES WITH CONCENTRIC REMODELLING OF THE LEFT VENTRICLE AND PREDICTS THE LONGITUDINAL EVOLUTION OF THIS ALTERATION BOTH IN STAGE G1-5 CKD PATIENTS AND IN DIALYSIS PATIENTS 46
Real-world effectiveness and safety of guselkumab for the treatment of psoriasis: A 6-month prospective study in a series of psoriatic patients 45
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 42
Mendelian randomization: a new approach to studying epidemiology in ESRD 42
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 41
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 41
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
The rs17384213 polymorphism in the DDAH1 gene is a marker of chronic allograft dysfunction. 39
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 39
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 37
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: Evidence for interaction with obesity in diabetic patients 37
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 37
Polymorphismes des gènes du système rènine et progression de l'atteinte rènale : une revue critique 35
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 34
An additive effect of endothelial nitric oxide synthase gene polymorphism contributes to the severity of atherosclerosis in patients on dialysis. 34
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 33
Joint effect of insulin signaling genes on all-cause mortality 33
CMTM8 variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/ polymorphonuclear myeloid-derived suppressor cell activity 32
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 32
Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients 32
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 31
Genetic polymorphisms of the ?-adrenergic system: Association with essential hypertension and response to ?-blockade 30
The deletion polymorphism of the angiotensin-converting-enzyme is associated with nephroangiosclerosis 29
Acido urico, polimorfismo del rene SLCA9, ipertensione e aterosclerosi: un potenziale rapporto causale. 29
Endothelial nitric oxide sinthase (eNOS) polymorphism interacts with asimmetric dimethyl arginine (ADMA) in determining all cause and cardiovascular mortality in patients with ESRD. 28
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism 28
Infiammazione sistemica ed espressione genica nel tessuto adiposo sottocutaneo delle citochine infiammatorie nei pazienti con insufficienza renale cronica. 28
Interazione tra le varianti geniche della Caveolina-1 e dell'ossido nitrico sintetasi nel determinare la severità dell'aterosclerosi carotidea nei pazienti in dialisi. 28
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. 28
ACE-genotype and ACE-inhibitors-induced renoprotection in chronic proteinuric nephrophaties 27
LOW FT3 AMPLIFIES THE RISK BY HYPERFIBRINOGENEMIA FOR ALL CAUSE AND CARDIOVASCULAR MORTALITY IN ESKD PATIENTS ON DIALYSIS 27
Interazioni tra le varianti geniche dell'ossido nitrico sintetasi e l'ADMA plasmatica nella mortalità cardiovascolare nei pazienti in dialisi 26
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance 26
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. 26
Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. 26
Valore prognostico della variante Glu298Asp dell'ossido nitrico sintetasi (eNOS) e dell'interazione eNOS-Arginina Asimmetrica (ADMA) nei pazienti in dialisi. 25
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review 25
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease 25
Le componenti funzionali che controllano la sintesi e la degradazione della dimetil-arginina asimmetrica (ADMA) sono espresse nel tessuto adiposo. 24
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 23
Linkage disequilibrium patterns and tagSNP transferability among European populations. 23
Il polimorfismo T585C del gene del ricettore Y2 del neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel determinismo dell'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 22
I polimorfismi del gene che regola la sintetasi dell'ossido nitrico contribuiscono all'aterosclerosi nei pazienti in dialisi. 22
Il polimorfismo C242T del gene per la subunità p22 dell'NADPH e il rischio cardiovascolare nei pazienti in dialisi. 21
L'allele T della variante GLU298ASP dell'ossido nitrico sintetasi (eNOS) è un fattore predittivo indipendente di aterosclerosi carotidea nei pazienti in dialisi. 21
Studio sulla molecola dell Asymmetric Dimethyl Arginino (ADMA) nei pazienti in dialisi (CREED) 2004. 21
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review. 20
Neuropeptide Y receptor Y2 (NPY2R) gene polymorphism is a modifier for the effect of NPY on left ventricular mass index (LVMI) and it is associated with carotid atherosclerosis in end stage renal disease (ESRD) patients. 20
The interaction of a common variant of the eNOS gene with asymmetric dimethylarginine (ADMA) in carotid atherosclerosis in end stage renal disease (ESRD). 20
Polymorphisms within the endpthelial nitric oxide synthase gene interact with plasma ADMA in predicting cardiovascular mortality in ESRD patients 20
Progetto Internazionale European LD Pattern Project 2004-2005. 19
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. 19
eNOS gene polymorphisms contribute to the severity of carotid atherosclerosis in dialysis patients. 18
Il polimorfismo L554F del gene della E-selettina è associato con l'ispessimento intimale, stenosi e rimodellamento vascolare in pazienti in dialisi. 17
Vitamin D Receptor (VDR) gene polymorphism and LVH in end stage renal disease (ESRD) patients: a longitudinal study. 17
The severity of carotid atherosclerosis is strongly associated with a polymorphism in the E-selectin gene in patients with end stage renal disease (ESRD). 14
Il polimorfismo rs17384213 nel gene ddah1 è un marker di disfunzione cronica del trapianto 6
null 5
Totale 3.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.805
article - articoli 8.293
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 100
Totale 19.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202482 0 0 0 0 0 0 0 0 59 0 23 0
2024/20251.164 8 2 84 105 236 24 21 66 73 48 278 219
2025/20261.951 87 210 166 255 322 94 310 130 84 140 104 49
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 3.200